Science First: Unleashing the Power of the Microbiome

Dec 12 2017

Did you know that there are more microbes in the human body than there are stars in the Milky Way? Today, the microbiome space is teeming with innovation. Research continues to reveal more about the power of the microbiome and it’s potential to play a role in disease prevention, immune system regulation, brain development and more. But, as an entrepreneur, much of the path to developing technologies in the area is uncharted. Come hear from four innovators currently developing unique solutions leveraging the microbiome right here at JLABS. They’ll present an overview of their science, then dig into research methods, challenges and insights for success in this space at a panel discussion.

Join Johnson & Johnson Innovation, JLABS and top San Diego innovators as they share data and insights to advance our understanding of this fascinating and complex field.

  • Regulatory challenges in the microbiome space
  • Disease areas and treatment modalities
  • Microbiome research methods
  • Intellectual property considerations
  • What partners are looking for in the microbiome space

Presenting Companies:
Dermala Inc read bio»
Persephone Biome read bio»
ProdermIQ Inc. read bio»
Xycrobe Therapeutics read bio»

3:00pm | Registration and networking
3:25pm | Introduction
3:30pm | Presentations
4:30pm | Panel Discussion and Q&A
5:30pm | Networking Reception*
6:30pm | Program Close
*Hors d’oeuvres and beverages provided

Who should attend: Entrepreneurs, scientists, industry professionals, advisors and investors interested in the microbiome space.

$35 | General Public
$25 | Student/Academic
$45 | At the door

JLABS San Diego
3210 Merryfield Row
San Diego, CA

About the Science First series:
The Science First series, sponsored by Johnson & Johnson Innovation, JLABS, brings together top experts to explore pressing topics in their scientific field. It is a chance for local scientists, researchers, and entrepreneurs to present and dialogue on new discoveries, advancing techniques, and other cutting-edge science themes.

Presenting Company Descriptions:
Dermala Inc
Dermala Inc is utilizing the human microbiome to develop the next generation of therapeutic and consumer healthcare products for treating diseases and disorders of the skin and improving human health. Web:

Persephone Biome
Persephone is a business taking a unique approach to gut microbiome health, understanding and leveraging the rich metabolic capabilities of the microbes themselves to develop targeted nutritional products and better therapeutic drugs.

ProdermIQ Inc
ProdermIQ, Inc., is a skin care startup whose mission is to leverage the microbiome, data analytics and machine learning to identify novel skin care solutions that get the right product to the right person at the right time. The company has bootstrapped to create the world’s first objective skin health measurement tool targeting the $100+ billion consumer skin care market by providing some of the largest skin care companies with consumer engagement tools, personalized ingredients and lifestyle recommendations.

Xycrobe Therapeutics
Xycrobe Therapeutics, Inc is a privately held, early-stage biotechnology company located in La Jolla, CA. Xycrobe is developing innovations that take advantage of the ubiquitous nature of these microbes by turning them into vehicles for the delivery of biotherapeutics. The goal is to develop better solutions for an array of clinical indications, with an initial focus on inflammatory skin diseases.